Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Cuncai Zhou
Observed names:
C Y Zhou,
Cun-Cai Zhou
Institutions:
Jiangxi Provincial Cancer Hospital,
Nanchang Medical College
Observed institutions:
Changzhi Medical College,
Jiangxi Provincial Cancer Hospital,
Hebei Yanda Ludaopei Hospital,
Nanchang Medical College
ORCID:
0000-0003-4709-0341
Observed ORCID:
0000-0003-4709-0341
OpenAlex ID:
A5103149305
Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
2021
·
Shukui Qin
, Qiu Li
, et al.
·
The Lancet. Gastroenterology & hepatology
·
280
Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition)
2022
·
Juxian Sun
, Rongping Guo
, et al.
·
Liver Cancer
·
118
Apatinib as second-line therapy in Chinese patients with advanced hepatocellular carcinoma: A randomized, placebo-controlled, double-blind, phase III study.
2020
·
Qiu Li
, Shukui Qin
, et al.
·
Journal of Clinical Oncology
·
35
Chinese Expert Consensus on Immunotherapy for Hepatocellular Carcinoma (2021 Edition)
2022
·
Yu Yang
, Juxian Sun
, et al.
·
Liver Cancer
·
23
PDF
Chinese multicenter expert consensus on the diagnosis and treatment of hilar cholangiocarcinoma: 2025 edition
2025
·
Sulai Liu
, Jinqiong Jiang
, et al.
·
BioScience Trends
·
11
PDF
Retrospective analysis of sorafenib efficacy and safety in Chinese patients with high recurrence rate of post-hepatic carcinectomy
2019
·
Desheng Wang
, Weridong Jia
, et al.
·
OncoTargets and Therapy
·
9
PDF
Tumors of the Skin
2018
·
Yong-Hang Zhu
, Gui-Xiu Zhang
, et al.
·
Springer eBooks
·
7
Adjuvant benmelstobart plus anlotinib in patients with high-risk recurrence after resection of hepatocellular carcinoma: a phase II study (ALTER-H006)
2025
·
Xiaohui Duan
, Dongde Wu
, et al.
·
Nature Communications
·
4
PDF
Synchronous hepatectomy and splenectomy for patients with BCLC stage 0/A hepatocellular carcinoma and clinically significant portal hypertension: A multicenter retrospective cohort study
2025
·
Tianyin Shao
, Hongwei Huang
, et al.
·
European Journal of Surgical Oncology
·
3
PDF
[Cell morphological analysis of hepatosplenic T-cell lymphoma gamma-delta type].
2020
·
P Wu
, H P Sun
, et al.
·
PubMed
·
1
Updated results of ALTER-H006: A phase II study of benmelstobart (PD-L1 inhibitor) plus anlotinib as adjuvant therapy in hepatocellular carcinoma (HCC) with high risk of recurrence after radical resection.
2025
·
Xianhai Ma0
, Xiaohui Duan
, et al.
·
Journal of Clinical Oncology
PDF
Show more works
View as search
Works count:
11
Citation count:
491
H-index:
7
I10-index:
5
Year
Topic
Type